4//SEC Filing
Havey Adam 4
Accession 0001367644-21-000049
CIK 0001367644other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:07 PM ET
Size
13.6 KB
Accession
0001367644-21-000049
Insider Transaction Report
Form 4
Havey Adam
EVP, BioDefense Division
Transactions
- Exercise/Conversion
Common Stock
2021-03-01$30.63/sh+17,134$524,814→ 55,324 total - Sale
Common Stock
2021-03-01$99.62/sh−17,134$1,706,889→ 38,190 total - Exercise/Conversion
Common Stock
2021-03-01$49.64/sh+20,145$999,998→ 58,335 total - Sale
Common Stock
2021-03-01$99.02/sh−20,145$1,994,758→ 38,190 total - Exercise/Conversion
Employee Stock Options (Right to Buy)
2021-03-01$99.62/sh−17,134$1,706,889→ 0 totalExercise: $30.63Exp: 2024-02-27→ Common Stock (17,134 underlying) - Exercise/Conversion
Employee Stock Options (Right to Buy)
2021-03-01$99.02/sh−20,145$1,994,758→ 0 totalExercise: $49.64Exp: 2025-02-26→ Common Stock (20,145 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25.
- [F3]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99.
- [F4]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001514588
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:07 PM ET
- Size
- 13.6 KB